WST
West Pharmaceutical Services, Inc. (WST)
Last Price$228.1(1.8%)
Market Cap$16.9B
Last Earnings date
Sep'24
Q3 2024
$1.78
3.5% beat
Next quarter EPS Estimate
$1.71
(6.6%)YoY

WST Earnings and Expectations

Revenue

Crunching data... Almost there!

WST EPS (Earnings Per Share)

Crunching data... Almost there!

WST Historical Revenue & EPS and Expectations

1Y
3Y
5Y
10Y
Revenue
EPS
$0.0$200.0M$400.0M$600.0M$800.0MApr'20Jul'20Oct'20Jan'21Apr'21Jul'21Oct'21Jan'22Apr'22Jul'22Oct'22Jan'23Apr'23Jul'23Oct'23Jan'24Apr'24Jul'24Oct'24$491.5M$548.0M$670.7M$706.5M$720.0M$686.9M$716.6M$747.4M$695.4M$746.9M
Value Sense
Actual Revenue
Forecast Revenue

WST Earnings History

Mar'15Jun'15Sep'15Dec'15Mar'16Jun'16Sep'16Dec'16Mar'17Jun'17Sep'17Dec'17Mar'18Jun'18Sep'18Dec'18Mar'19Jun'19Sep'19Dec'19Mar'20Jun'20Sep'20Dec'20Mar'21Jun'21Sep'21Dec'21Mar'22Jun'22Sep'22Dec'22Mar'23Jun'23Sep'23Dec'23Mar'24Jun'24Sep'24Dec'24
Revenue actual$335.9M$359.7M$344.5M$359.7M$362.1M$388.0M$376.7M$382.3M$387.7M$397.6M$398.2M$415.6M$415.7M$447.5M$431.7M$422.5M$443.5M$469.7M$456.1M$470.6M$491.5M$527.2M$548.0M$580.2M$670.7M$723.6M$706.5M$730.8M$720.0M$771.3M$686.9M$708.7M$716.6M$753.8M$747.4M$732.0M$695.4M$702.0M$746.9M$748.8M
Revenue estimate$298.6M$298.6M$298.6M$298.6M$348.4M$348.4M$348.4M$348.4M$263.3M$263.3M$263.3M$263.3M$429.1M$429.1M$429.1M$429.1M$431.0M$461.4M$450.8M$451.5M$466.8M$496.1M$502.7M$540.4M$604.0M$669.4M$687.1M$710.2M$720.9M$754.3M$727.4M$657.2M$698.2M$755.7M$750.3M$739.5M$670.6M$729.4M$709.6M$740.1M
Revenue surprise12.5%20.5%15.4%20.5%3.9%11.4%8.1%9.7%47.3%51.0%51.3%57.9%3.1%4.3%0.6%1.5%2.9%1.8%1.2%4.2%5.3%6.3%9.0%7.4%11.0%8.1%2.8%2.9%0.1%2.3%5.6%7.8%2.6%0.3%0.4%1.0%3.7%3.8%5.3%1.2%
EPS actual$0.46$0.39$0.02$0.46$0.31$0.61$0.51$0.53$0.83$0.53$0.69($0.03)$0.59$0.76$0.75$0.70$0.75$0.90$0.76$0.86$1.01$1.24$1.11$1.33$2.04$2.53$2.37$1.98$2.34$2.53$1.62$1.38$1.88$2.09$2.17$1.85$1.57$1.52$1.87$1.78
EPS estimate$0.35$0.35$0.35$0.35$0.49$0.49$0.49$0.49$0.32$0.32$0.32$0.32$0.66$0.66$0.66$0.66$0.66$0.72$0.71$0.72$0.82$0.91$0.99$1.12$1.43$1.74$1.80$1.92$2.12$2.21$2.12$1.38$1.67$1.93$1.86$1.78$1.27$1.74$1.50$1.72
EPS surprise31.4%11.4%94.3%31.4%36.7%24.5%4.1%8.2%159.4%65.6%115.6%110.5%10.6%15.2%13.6%6.1%14.2%24.7%7.3%19.3%22.9%36.6%11.7%18.2%42.5%45.4%31.9%3.4%10.2%14.6%23.6%0.3%12.7%8.5%16.9%4.0%23.3%12.7%24.6%3.5%

Overview of financial statements

Income statement
Balance sheet
Cash Flow statement
$748.8M 2.3% YoY
$273.6M (1.7%) YoY
36.5% margin
Cost of revenue
$475.2M 4.7% YoY
Operating income
$159.6M (0.8%) YoY
21.3% margin
Other: $300.0K
Net interest: $5,600.0K
Operating expenses
$114.0M 5.2% YoY
Pre-tax income
$164.9M (2.0%) YoY
22.0% margin
Net income
$130.1M (5.0%) YoY
17.4% margin
Income tax
$36.8M
22.3% tax rate
R&D
$18.5M 0.5% YoY
2.5% of revenue
SG&A
$85.3M (5.2%) YoY
11.4% of revenue

Competing with WST Earnings

Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name
Market Cap
Revenue
EPS
Last quarter Revenue growth
Last quarter EPS growth
Last quarter Revenue surpriseLast quarter EPS surprise
Next quarter Revenue growth
Next quarter EPS growth
Last 10 Earnings (how many miss vs beat)
1Y Fwd Revenue growth
1Y Fwd EPS growth
$16.9B
$2,893.1M
$6.74
2.3%
(3.8%)
Beat by 1.2%
Beat by 3.5%
(2.8%)
(6.1%)
Beats:
Misses:
5.3%
10.7%
$207.3B
$8,352.1M
$8.46
25.2%
123.8%
Beat by 7.8%
Beat by 117.1%
(8.7%)
(53.6%)
Beats: 8
Misses: 2
14.2%
20.5%
$66.3B
$20.6B
$6.03
9.8%
8.2%
Beat by 1.2%
Miss by 64.8%
5.5%
228.9%
Beats: 8
Misses: 2
9.0%
145.1%
$46.6B
$9,926.1M
$1.48
0.9%
(100.0%)
Beat by 2.8%
Miss by 100.0%
1.1%
0.0%
Beats: 8
Misses: 2
2.8%
50.8%
$34.6B
$4,926.8M
$4.03
10.3%
N/A
Beat by 1.1%
Miss by 191.3%
1.3%
(213.5%)
Beats: 7
Misses: 3
9.2%
35.4%
$18.6B
$3,895.4M
$1.97
9.8%
34.9%
Beat by 2.1%
Miss by 36.3%
(3.9%)
57.8%
Beats: 6
Misses: 4
5.8%
102.2%
$17.9B
$12.9B
($1.28)
(29.1%)
N/A
undefinedN/A
undefinedN/A
(4.6%)
(150.5%)
Beats: 6
Misses: 4
148.7%
N/A
$14.7B
$4,038.9M
$3.18
0.9%
(15.5%)
Beat by 4.5%
Miss by 14.1%
1.0%
19.0%
Beats: 8
Misses: 2
3.4%
27.1%
$10.4B
$2,094.4M
($5.68)
9.4%
N/A
Beat by 19.5%
Miss by 879.3%
(16.8%)
(115.8%)
Beats: 9
Misses: 1
1.9%
161.9%
$9,757.8M
$3,582.9M
$5.65
1.1%
60.0%
Miss by 0.7%
Beat by 20.6%
10.6%
(14.1%)
Beats: 9
Misses: 1
5.0%
4.4%

FAQ

1. When was West Pharmaceutical Services, Inc.'s last earnings date?

West Pharmaceutical Services, Inc.'s last earnings date was Sep'24 (Q3 2024).

4. What is West Pharmaceutical Services, Inc.'s next quarter EPS estimate?

West Pharmaceutical Services, Inc.'s next quarter EPS estimate is $1.71, with an expected (6.6%) YoY growth.